Gene Therapy
AAV analysis allows researchers to determine titer, full:empty capsid ratio, and aggregation in single 30-minute run
| 2 min read
Located on the Tufts University Medford, MA campus, this new donor center will enable delivery of fresh blood, leukopaks, and buffy coats for COVID-19, cell, and gene therapy research within hours of collection
| 3 min read
TheraPEAK™ SfAAV™ Medium is specifically designed to support the development of safe, scalable, life-saving gene therapies
| 2 min read
BioIVT’s acquisition of Clinical Trial Laboratory Services (CTLS) and its London donor center is enabling this rapid turnaround time for high quality blood-derived immune cells for cell and gene therapy research
| 3 min read
Researchers have developed a novel gene therapy to regenerate functional new neurons in mouse models of Huntington's disease
| 3 min read
New data on first-in-US trial sheds new light on success of gene editing and cell function
| 4 min read
Treatment uses person's own stem cells instead of donor cells
| 4 min read
Next-generation gene editing system has applications in development of cell and gene therapies
| 3 min read
Technique developed at Human Genome and Stem Cell Research Center, funded by FAPESP and hosted by the University of São Paulo, produced hepatic tissue in the laboratory in only 90 days and could become an alternative to organ transplantation in future
| 3 min read
Japanese researchers led by Osaka University show that a Class 1 CRISPR gene editing system can achieve functional DNA repairs in human cells with no prominent off-target effects
| 2 min read
